Kerr D J, Smart H E
Beatson Oncology Centre, Belvidere Hospital, Glasgow, Scotland, UK.
In Vivo. 1991 Jul-Aug;5(4):385-8.
Doxorubicin has been shown to be more effective against MGH-U1 bladder carcinoma cells grown in monolayer than spheroid. In vitro clonogenic cell survival curves have been replotted against the area under the concentration-time curve (AUC) for drug exposure and fitted to a Hill plot to derive the parameters E max (maximum possible cell kill) and C50 (drug exposure resulting in half the maximum cell kill). The plasma AUC following intraperitoneal administration of doxorubicin to nude mice was measured using a sensitive and specific HPLC assay and combined with the in vitro cell survival parameters to predict the clonogenic cell survival in MGH-U1 xenografts. The Hill parameters from the spheroid model are better predictors of xenograft clonogenic cell survival than the monolayer parameters. It is possible to predict clonogenic cell survival in solid tumours on the basis of the pharmacokinetics of cytotoxic drug exposure, using a mathematical model based on clonogenic cell kill in vitro.
已证明阿霉素对单层培养的MGH-U1膀胱癌细胞比球体培养的细胞更有效。体外克隆形成细胞存活曲线已根据药物暴露的浓度-时间曲线下面积(AUC)重新绘制,并拟合到希尔图以得出参数E max(最大可能的细胞杀伤)和C50(导致最大细胞杀伤一半的药物暴露)。使用灵敏且特异的高效液相色谱法测定裸鼠腹腔注射阿霉素后的血浆AUC,并将其与体外细胞存活参数相结合,以预测MGH-U1异种移植瘤中的克隆形成细胞存活情况。球体模型的希尔参数比单层参数更能预测异种移植瘤的克隆形成细胞存活情况。使用基于体外克隆形成细胞杀伤的数学模型,根据细胞毒性药物暴露的药代动力学来预测实体瘤中的克隆形成细胞存活情况是可行的。